Focus on colon cancer

Cancer Cell

Volumn 1, Issue 3, 2002, Pages 233-236

  Markowitz, Sanford D ^a,c,d   Dawson, Dawn M ^b   Willis, Joseph ^c   Willson, James K V ^c,d  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CETUXIMAB; CYCLOOXYGENASE 2 INHIBITOR; CYTOTOXIC AGENT; FLUOROURACIL; GROWTH FACTOR; IRINOTECAN; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MONOCLONAL ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; RAPAMYCIN DERIVATIVE;

ADENOMATOUS POLYP; CANCER CHEMOTHERAPY; CANCER GENETICS; CANCER GROWTH; CANCER INHIBITION; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; COLON CANCER; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; COLON TUMOR; GENETICS;

COLONIC NEOPLASMS; HUMANS;

EID: 0036528298     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(02)00053-3     Document Type: Review

References (34)

1. Ahlquist, D.A., and Shuber, A.P. (2002). Stool screening for colorectal cancer: evolution from occult blood to molecular markers. Clin. Chim. Acta 315, 157-168.
2. Boland, C., Thibodeau, S., Hamilton, S., Sidransky, D., Eshlaman, J., Burt, R., Meltzer, S., Rodriguez-Bigas, M., Fode, R., Ranzani, G., and Srivastava, S. (1998). A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: Development of internaltional criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 58, 5248-5257.
3. Eshleman, J., Lang, E., Bowerfind, G., Parsons, R., Vogelstein, B., Willson, J., Veigl, M., Sedwick, W.D., and Markowitz, S. (1995). Increased mutation rate at the hprt locus accompanies microsatellite instability in colon cancer. Oncogene 10, 33-37.
4. Fearon, E., and Gruber, S. (2001). Molecular abnormalities in colon and rectal cancer. In The Molecular Basis of Cancer, J. Mendelsohn, P. Howley, M. Israel, and L. Liotta, eds. (Philadelphia, W.B. Saunders), pp. 289-312.
5. Goss, K.H., and Groden, J. (2000). Biology of the adenomatous polyposis coli tumor suppressor. J. Clin. Oncol. 18, 1967-1979.
6. Grady, W.M., Rajput, A., Lutterbaugh, J.D., and Markowitz, S.D. (2001). Detection of aberrantly methylated hMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer. Cancer Res. 61, 900-902.
7. Greenlee, R.T., Hill-Harmon, M.B., Murray, T., and Thun, M. (2001). Cancer statistics, 2001. CA Cancer J. Clin. 51, 15-36.
8. Jiang, D., Yang, H., Willson, J.K., Liang, J., Humphrey, L.E., Zborowska, E., Wang, D., Foster, J., Fan, R., and Brattain, M.G. (1998). Autocrine transforming growth factor alpha provides a growth advantage to malignant cells by facilitating re-entry into the cell cycle from suboptimal growth states. J. Biol. Chem. 273, 31471-31479.
9. Kinzler, K., and Vogelstein, B. (1996). Lessons from hereditary colorectal cancer. Cell 87, 159-170.
10. Kolodner, R. (1996). Bochemistry and genetics of eukaryotic mismatch repair. Genes Dev. 10, 1433-1442.
11. Kolodner, R., Tytell, J., Schmeits, J., Kane, M., Das Gupta, R., Weger, J., Wahlberg, S., Fox, E., Peel, D., Ziogas, A., et al. (1999). Germ-line msh6 mutations in colorectal cancer families. Cancer Res. 59, 5068-5074.
12. Lengauer, C., and Vogelstein, B. (1998). Genetic instabilities in human cancers. Nature 396, 643-649.
13. Markowitz, S. (2000). TGF-beta receptors and DNA repair genes, coupled targets in a pathway of human colon carcinogenesis. Biochim. Biophys. Acta 1470, M13-M20.
14. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R., Zborowska, E., Kinzler, K., Vogelstein, B., et al. (1995). Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268, 1336-1338.
15. Mendelsohn, J., and Baselga, J. (2000). The EGF receptor family as targets for cancer therapy. Oncogene 19, 6550-6565.
16. Moinova, H.R., Chen, W.D., Shen, L., Smiraglia, D., Olechnowicz, J., Ravi, L., Kasturi, L., Myeroff, L., Plass, C., Parsons, R., et al. (2002). HLTF gene silencing in human colon cancer. Proc. Natl. Acad. Sci. USA 99, 4562-4567.
17. Oshima, M., Dinchuk, J.E., Kargman, S.L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J.M., Evans, J.F., and Taketo, M.M. (1996). Suppression of intestinal polyposis in APC delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87, 803-809.
18. Roberts, R.B., Min, L., Washington, M.K., Olsen, S.J., Settle, S.H., Coffey, R.J., and Threadgill, D.W. (2002). Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis. Proc. Natl. Acad. Sci. USA 99, 1521-1526.
19. Saha, S., Bardelli, A., Buckhaults, P., Velculescu, V.E., Rago, C., St Croix, B., Romans, K.E., Choti, M.A., Lengauer, C., Kinzler, K.W., and Vogelstein, B. (2001). A phosphatase associated with metastasis of colorectal cancer. Science 294, 1343-1346.
20. Saltz, L.B., Cox, J.V., Blanke, C., Rosen, L.S., Fehrenbacher, L., Moore, M.J., Maroun, J.A., Ackland, S.P., Locker, P.K., Pirotta, N., et al. (2000). Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N. Engl. J. Med. 343, 905-914.
21. Saltz, L., Rubin, M., Hochster, H., Tchekmeydian, S., Waksal, H., Needle, M., and LoBuglio, A. (2001). Cetuximab (IMC-C225) plus irinotecan (CPT-11) is active in CPT-11-refractory colorectal cancer (CRC) that expresses Epidermal Growth Factor Receptor (EGFR). Proc. Amer. Soc. Clin. Onc. 20, 3a.
22. Schoen, R.E. (2002). Science and Society: the case for population based screening for colorectal cancer. Nature Reviews Cancer 2, 65-70.
23. Skibber, J., Minsky, B., and Hoff, P. (2001). Cancer of the colon. In Cancer: Principles and Practice of Oncology, V. DeVita, S. Hellman, and S. Rosenberg, eds. (Philadelphia: Lippincott Williams and Wilkins), pp. 1216-1271.
24. Smith, R.A., von Eschenbach, A.C., Wender, R., Levin, B., Byers, T., Rothenberger, D., Brooks, D., Creasman, W., Cohen, C., Runowicz, C., et al. (2001). American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. CA Cancer J. Clin. 51, 38-75.
25. Stack, E., and DuBois, R.N. (2001). Role of cyclooxygenase inhibitors for the prevention of colorectal cancer. Gastroenterol. Clin. North Am. 30, 1001-1010.
26. Torrance, C.J., Jackson, P.E., Montgomery, E., Kinzler, K.W., Vogelstein, B., Wissner, A., Nunes, M., Frost, P., and Discafani, C.M. (2000). Combinatorial chemoprevention of intestinal neoplasia. Nat. Med. 6, 1024-1028.
27. Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J., Baylin, S., and Issa, J.P. (1999). CpG island methylator phenotype in colorectal cancer. Proc. Natl. Acad. Sci. USA 96, 8681-8686.
28. Traverso, G., Shuber, A., Levin, B., Johnson, C., Olsson, L., Schoetz, D.J., Jr., Hamilton, S.R., Boynton, K., Kinzler, K.W., and Vogelstein, B. (2002). Detection of APC mutations in fecal DNA from patients with colorectal tumors. N. Engl. J. Med. 346, 311-320.
29. Velcich, A., Yang, W., Heyer, J., Fragale, A., Nicholas, C., Viani, S., Kucherlapati, R., Lipkin, M., Yang, K., and Augenlicht, L. (2002). Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 295, 1726-1729.
30. Watanabe, T., Wu, T.T., Catalano, P.J., Ueki, T., Satriano, R., Haller, D.G., Benson, A.B., 3rd, and Hamilton, S.R. (2001). Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N. Engl. J. Med. 344, 1196-1206.
31. Willett, W.C. (2001). Diet and cancer: one view at the start of the millennium. Cancer Epidemiol. Biomarkers Prev. 10, 3-8.
32. Yan, H., Papadopoulos, N., Marra, G., Perrara, C., Jiricny, J., Boland, C.R., de la Chapelle, A., Berg, K., Eshleman, J., Yuan, W., et al. (2000). Conversion of diploidy to haploidy. Nature 403, 723-724.
33. Yan, H., Dobbie, Z., Gruber, S.B., Markowitz, S., Romans, K., Giardiello, F.M., Kinzler, K.W., and Vogelstein, B. (2002). Small changes in expression affect predisposition to tumorigenesis. Nat. Genet. 30, 25-26.
34. Zhou, W., Goodman, S.N., Galizia, G., Lieto, E., Ferraraccio, F., Pignatelli, C., Purdie, C.A., Piris, J., Morris, R., Harrison, D.J., et al. (2002). Counting alleles to predict recurrence of early-stage colorectal cancers. Lancet 359, 219-225.